UPDATE: Baird Upgrades Enanta Pharmaceuticals (ENTA) to Outperform
Tweet Send to a Friend
(Updated - March 17, 2020 7:05 AM EDT)
Baird analyst Brian Skorney upgraded Enanta Pharmaceuticals (NASDAQ: ENTA) from Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Baird analyst Brian Skorney upgraded Enanta Pharmaceuticals (NASDAQ: ENTA) from Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
